Good Growth Capital

Good Growth Capital is a venture capital firm based in Charleston, South Carolina, specializing in early-stage investments in transformative science and technology companies. The firm focuses on sectors such as life sciences, data sciences, and greentech/hard sciences, aiming to deliver exceptional returns for its investors. Good Growth Capital is known for its ability to source, assess, and invest in innovative businesses that are poised for growth, particularly in software, healthcare technology systems, materials and resources, and energy sectors. The firm emphasizes a strategic approach to identifying opportunities that leverage cutting-edge advancements to drive positive change and economic value.

Maureen Stanick Boyce

Managing Partner and Founder

Robert Critchfield

Operating Partner

Sophie Hagerty

Principal

Krisztina 'Z' Holly

Operating Partner

David Mendez

Managing Partner

Amy Salzhauer

Founder and Managing Partner

Samuel Scofield

Associate

114 past transactions

Hoofprint Biome

Series A in 2025
Hoofprint Biome is a developer of probiotics that improve the sustainability of ruminant livestock production. Its probiotics and natural enzymes improve cattle health and digestive care by eliminating methane and enabling the livestock industry to catalyze the symbiotic agriculture movement with microbiome engineering.

AdipoPharma

Venture Round in 2024
AdipoPharma SAS focuses on advancing treatments for insulin resistance and type 2 diabetes by harnessing the unique properties of adipocyte cells. The company develops peptide-based drugs aimed at improving insulin sensitivity and controlling blood glucose levels in patients. AdipoPharma's approach involves a comprehensive genetic analysis of conditions such as Alström syndrome and utilizes therapeutic peptides that target specific pathways to enhance lipid biosynthesis in diseased adipocytes. This targeted methodology not only addresses insulin resistance but also aims to reduce liver fibrosis and steatosis, offering low-risk treatment options for individuals managing diabetes and its associated comorbidities.

Aralez Bio

Series A in 2024
Aralez Bio specializes in the sustainable production of noncanonical amino acids (ncAAs), which are also known as unusual or unnatural amino acids. The company has developed a novel enzymatic method that allows for the synthesis of over 100 ncAAs with perfect enantiopurity in a single step, using water as the sole byproduct. This innovative approach provides clients with access to essential amino acids required for advancements in pharmaceuticals, agriculture, and functional materials, thereby supporting various sectors in their product development efforts.

Liminal

Venture Round in 2024
Liminal, formerly known as Feasible, Inc., specializes in battery analytics through its innovative EchoStat platform, which utilizes ultrasound waves to assess the physical properties of batteries. By sending ultrasonic pulses through a battery and analyzing the resulting echoes, Liminal can detect differentials within individual cells, across multiple cells, and even between production lines. This technology allows for real-time insights into the electrical, thermal, and mechanical conditions of battery components, making it particularly valuable for industries such as automotive, residential storage, grid storage, and consumer electronics. Founded in 2015 and headquartered in Emeryville, California, Liminal is positioned to enhance battery performance and reliability through its advanced screening and analytics capabilities.

VenoStent

Series A in 2024
VenoStent, Inc. is a clinical-stage tissue engineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Founded in 2017, it specializes in the development of bioresorbable smart polymers designed to enhance vascular surgery outcomes. The company’s primary product, SelfWrap, is a perivascular wrap that functions as an external stent, providing mechanical support to veins and promoting outward growth. This innovative technology aims to reduce complications at the vein-artery junction in dialysis patients, particularly by minimizing vein collapse and improving the usability of arteriovenous fistulas (AVF). By utilizing a new class of shape-memory polymers that do not require sutures, VenoStent's approach reduces surgery time and lowers the risk of infection, ultimately enhancing the quality and length of life for patients with chronic kidney disease undergoing hemodialysis.

Swift Solar

Series A in 2024
Swift Solar Inc. is a company that designs and manufactures lightweight solar panels and systems, focusing on advanced solar technology. Established in 2017 and headquartered in San Carlos, California, with an additional site in Golden, Colorado, Swift Solar specializes in perovskite solar cells, which are engineered to be more efficient and cost-effective than conventional solar panels. The company’s innovative approach involves creating ultra-thin perovskite films that absorb various parts of the solar spectrum, resulting in high-efficiency tandem solar cells. These cells not only enhance solar conversion efficiency but also provide significant weight advantages, making them suitable for applications in aerospace, automotive, and building sectors. Swift Solar emphasizes domestic manufacturing and utilizes abundant raw materials to ensure scalability in its operations.

Found Energy

Seed Round in 2024
Found Energy is a renewable energy company focused on transforming aluminum into a renewable energy carrier. The company specializes in recovering aluminum waste from landfills and employs a carbon-free process to generate hydrogen on demand, achieving production costs under $0.50 per kilogram. This process yields hydrogen with five times the volumetric energy density of liquid hydrogen, making it a viable alternative to fossil fuels. By providing a sustainable energy solution, Found Energy aims to support heavy industries in their transition to renewable energy sources while maintaining competitive pricing and energy efficiency.

Pienso

Series A in 2024
Pienso Inc. is a machine learning platform based in Brooklyn, New York, that specializes in transforming text data into actionable insights. Established in 2016, the company employs innovative lensing techniques to enhance both algorithms and user interactions, creating a real-time system for validation and adaptation. Its platform is designed specifically for non-programming analysts, researchers, and domain experts, allowing them to create and train machine learning models independently, without requiring external assistance. By providing feedback loops between users and machine analysis, Pienso facilitates improved data mining, prediction, and the visualization of associations, ultimately empowering its clientele to derive meaningful insights from their data.

Base Operations

Series A in 2023
Base Operations Inc. specializes in providing street-level threat analysis services through a comprehensive threat intelligence platform. Founded in 2015 and based in Washington, D.C., the company aggregates and visualizes both crowdsourced and official data to assist organizations in mitigating risks and ensuring the safety of their personnel and operations in emerging markets. Their offerings include detailed threat assessments, neighborhood threat ratings, and AI-powered predictive analytics, which enable clients to gain actionable insights for improved response times and security management. Additionally, the platform features a dashboard for security personnel, facilitating communication with field employees and enhancing trip management to safeguard against potential threats.

Next Power 360

Seed Round in 2023
NextPower360 develops generators and motors that are instantaneously adaptive to variable power inputs and outputs. NextPower360 aims to make electrical machines and technology that turn the tide in humanity’s fight against climate change. It offers an electric motor design that provides breakthrough range extension from smaller, simpler, lighter, and more efficient motor design, with improved power and regenerative braking. The company was founded in 2022 and is based in Asheville, NC.

AOA

Venture Round in 2023
AOA, based in Boston, New York, and London, is a female-led company focused on developing innovative cancer diagnostics specifically for women's health. The company is dedicated to creating the first accurate early-stage liquid biopsy test for ovarian cancer, which aims to enhance clinical practices, reduce patient mortality, and offer cost savings for healthcare payers. Utilizing an artificial intelligence-enabled platform, AOA's technology analyzes tumor marker gangliosides to facilitate the early detection of ovarian cancer. This approach not only helps healthcare providers implement more effective treatment strategies but also ensures that patients can access life-saving treatments sooner and at a more affordable cost.

Pryon

Series B in 2023
Pryon Inc. is an artificial intelligence company based in Raleigh, North Carolina, that focuses on enhancing enterprise knowledge management. Founded in 2017 by Igor Jablokov, Pryon develops an augmented intelligence platform that combines human and machine capabilities to streamline access to information across various channels and sources. The platform employs natural language processing and automated machine learning to transform unstructured data into actionable insights, thereby boosting productivity and decision-making accuracy. By utilizing a no-code approach, Pryon enables organizations to quickly harness the value of their information assets without disrupting existing operations. The company's solutions aim to simplify AI adoption, reduce complexity, and lower costs for businesses seeking to improve their workflows and knowledge utilization.

Lemurian Labs

Seed Round in 2023
Lemurian Labs is focused on transforming AI infrastructure through a universal compute platform that integrates training, inference, and deployment across various hardware environments. The company offers a cohesive software layer that replaces fragmented tools, utilizing a hardware-aware compiler and dynamic runtime for optimized performance. Central to this platform is Helix, a domain-specific language that converts high-level code into efficient, scalable execution compatible with diverse chips, memory, and clusters. By emphasizing performance, portability, and ease of use, Lemurian Labs empowers AI teams to accelerate development, streamline workflows, and deploy advanced AI applications effectively, regardless of organizational size or technical constraints.

Hoofprint Biome

Pre Seed Round in 2023
Hoofprint Biome is a developer of probiotics that improve the sustainability of ruminant livestock production. Its probiotics and natural enzymes improve cattle health and digestive care by eliminating methane and enabling the livestock industry to catalyze the symbiotic agriculture movement with microbiome engineering.

VenoStent

Series A in 2023
VenoStent, Inc. is a clinical-stage tissue engineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Founded in 2017, it specializes in the development of bioresorbable smart polymers designed to enhance vascular surgery outcomes. The company’s primary product, SelfWrap, is a perivascular wrap that functions as an external stent, providing mechanical support to veins and promoting outward growth. This innovative technology aims to reduce complications at the vein-artery junction in dialysis patients, particularly by minimizing vein collapse and improving the usability of arteriovenous fistulas (AVF). By utilizing a new class of shape-memory polymers that do not require sutures, VenoStent's approach reduces surgery time and lowers the risk of infection, ultimately enhancing the quality and length of life for patients with chronic kidney disease undergoing hemodialysis.

Blue Ocean Gear

Series A in 2023
Blue Ocean Gear specializes in the design and manufacture of advanced GPS tracking buoys, specifically engineered to meet the challenging demands of modern fixed gear fishing. Their innovative SmartBuoy product suite provides fishers, aquaculture farmers, and ocean scientists with the ability to track and monitor data from their equipment in real-time, regardless of location. This technology significantly improves operational efficiency and profitability by reducing fuel costs and minimizing the risk of lost gear, while also offering valuable insights into local ocean conditions. Additionally, Blue Ocean Gear's solutions contribute to addressing environmental issues related to marine plastic pollution and gear entanglement, promoting more sustainable management of ocean resources.

Fluree

Series A in 2023
Fluree is a developer of a data management platform that focuses on secure data sharing and data-driven insights. Its platform utilizes a blockchain-secured semantic graph database to organize data, providing a scalable solution that establishes a foundational layer of trusted information for connected and intelligent ecosystems. By reducing the need for custom code and excessive APIs, Fluree enables data-first development across the entire technology stack, ensuring a single source of data truth. This approach allows clients to make their data tamper-proof while benefiting from a cloud-native architecture.

Eden

Seed Round in 2023
Eden is focused on developing a sustainable platform for natural resource recovery, aiming to create a carbon-neutral future. The company has introduced a novel method known as Pulsed Electrical Well Stimulation (PEWS), which is a patent-pending technology designed to replace traditional hydraulic fracturing. This innovative approach eliminates the need for water injection and addresses the logistical challenges and environmental risks associated with conventional fracking methods. By utilizing high-voltage electricity and proprietary modeling techniques, Eden enhances rock permeability with precision, facilitating effective resource extraction across various geological settings. This technology not only reduces costs but also minimizes the negative impacts typically associated with hydraulic fracturing, positioning Eden as a leader in environmentally responsible resource recovery.

Robigo

Seed Round in 2023
Robigo is a biomanufacturing company focused on developing precision microbial treatments aimed at enhancing plant health and recovering lost agricultural yields. By leveraging microbial engineering and data science, Robigo creates sustainable crop protection solutions that are designed to be more effective and safe for beneficial microbes, pollinators, humans, and the environment. This innovative approach enables farmers to improve their productivity and profitability while promoting sustainable farming practices.

Liminal

Series A in 2023
Liminal, formerly known as Feasible, Inc., specializes in battery analytics through its innovative EchoStat platform, which utilizes ultrasound waves to assess the physical properties of batteries. By sending ultrasonic pulses through a battery and analyzing the resulting echoes, Liminal can detect differentials within individual cells, across multiple cells, and even between production lines. This technology allows for real-time insights into the electrical, thermal, and mechanical conditions of battery components, making it particularly valuable for industries such as automotive, residential storage, grid storage, and consumer electronics. Founded in 2015 and headquartered in Emeryville, California, Liminal is positioned to enhance battery performance and reliability through its advanced screening and analytics capabilities.

AdipoPharma

Series A in 2023
AdipoPharma SAS focuses on advancing treatments for insulin resistance and type 2 diabetes by harnessing the unique properties of adipocyte cells. The company develops peptide-based drugs aimed at improving insulin sensitivity and controlling blood glucose levels in patients. AdipoPharma's approach involves a comprehensive genetic analysis of conditions such as Alström syndrome and utilizes therapeutic peptides that target specific pathways to enhance lipid biosynthesis in diseased adipocytes. This targeted methodology not only addresses insulin resistance but also aims to reduce liver fibrosis and steatosis, offering low-risk treatment options for individuals managing diabetes and its associated comorbidities.

Avisi Technologies

Seed Round in 2022
Avisi Technologies Inc. is a company based in Philadelphia, Pennsylvania, that focuses on developing innovative solutions for glaucoma treatment. Founded in 2017, the company has created VisiPlate, a next-generation aqueous shunt that utilizes nanotechnology to provide a defense against blindness caused by glaucoma. This advanced technology aims to improve the effectiveness of glaucoma treatments and enhance patient outcomes.

Pryon

Venture Round in 2022
Pryon Inc. is an artificial intelligence company based in Raleigh, North Carolina, that focuses on enhancing enterprise knowledge management. Founded in 2017 by Igor Jablokov, Pryon develops an augmented intelligence platform that combines human and machine capabilities to streamline access to information across various channels and sources. The platform employs natural language processing and automated machine learning to transform unstructured data into actionable insights, thereby boosting productivity and decision-making accuracy. By utilizing a no-code approach, Pryon enables organizations to quickly harness the value of their information assets without disrupting existing operations. The company's solutions aim to simplify AI adoption, reduce complexity, and lower costs for businesses seeking to improve their workflows and knowledge utilization.

Boston Materials

Series A in 2022
Boston Materials, Inc. is a manufacturer of advanced composite materials, specializing in 3D reinforced carbon fiber pre-pregs. Founded in 2016 and based in Bedford, Massachusetts, the company utilizes patented Z-axis Fiber technology, which incorporates vertically aligned carbon fibers to enhance energy transfer properties. Its product line includes Carbon Supercomposite, a magnetically assembled carbon fiber pre-preg, which finds applications across various sectors such as aerospace, automotive, marine, wind energy, and sports equipment. Boston Materials' advanced materials aim to improve thermal, electrical, and mechanical properties, offering a roll-to-roll manufacturing process with in-line quality control and an annual production capacity of one million square meters. These innovations enable industries like semiconductors and electrified vehicles to achieve greater efficiency, reliability, and weight reduction while addressing critical challenges in durability and performance.

Fermata Discovery

Seed Round in 2022
Fermata Discovery is a cloud-based software company that specializes in developing artificial intelligence-driven tools to enhance investigative workflows. Its platform automates the gathering, assembly, analysis, and visualization of large volumes of data, enabling investigators to efficiently address complex cases such as financial fraud, security breaches, and missing persons. By streamlining routine processes, Fermata's solutions facilitate faster and more cost-effective resolutions, ultimately maximizing financial recoveries for its clients. The company collaborates with leading corporate investigation firms, law firms, and public sector agencies, providing them with the necessary software tools to improve problem-solving capabilities.

Leuko

Series A in 2022
Leuko Labs focuses on developing a non-invasive device for monitoring white blood cell counts, which is crucial for various medical situations, including chemotherapy management and the detection of severe infections. Their device, PointCheck, allows for frequent testing without the need for blood draws or laboratory infrastructure, making it more accessible for patients. This innovation aims to enhance the quality of life for immunosuppressed individuals and improve clinical outcomes by enabling healthcare providers to offer personalized treatment plans based on real-time data. By simplifying the process of white blood cell assessment, Leuko Labs contributes to more effective patient management and better survival rates.

Bounce Imaging

Series A in 2022
Bounce Imaging, Inc. specializes in the manufacturing of tactical throwable cameras equipped with multiple lenses and sensors, designed primarily for use by police and firefighters. The company's innovative products enable first responders to safely assess hazardous environments remotely, providing real-time video and sensor data while maintaining stability during movement. In addition to its camera systems, Bounce Imaging offers a variety of accessories, including pole attachments, tethers, car chargers, headsets, wrist straps, and magnetic mounts. The company also provides cloud-based services that encompass technical consulting, design and implementation support, and troubleshooting for imaging and processing hardware. Founded in 2012, Bounce Imaging is headquartered in Buffalo, New York.

Spectrohm

Seed Round in 2022
Spectrohm specializes in high-speed inspection solutions for packages and bags, utilizing innovative radio wave technology. The company's flagship products, CheckStream and CargoStream, are designed to assist governments, venues, and eCommerce businesses in detecting threats, enforcing tariffs, and preventing fraud more efficiently and cost-effectively than traditional inspection methods. By employing this advanced technology, Spectrohm enables high-throughput content identification, allowing for the detection of hazardous materials through their unique radio light signatures. This capability supports the development of fully autonomous inspection systems, offering comprehensive insights into package content and addressing issues related to small package fraud and security threats.

Liminal

Series A in 2022
Liminal, formerly known as Feasible, Inc., specializes in battery analytics through its innovative EchoStat platform, which utilizes ultrasound waves to assess the physical properties of batteries. By sending ultrasonic pulses through a battery and analyzing the resulting echoes, Liminal can detect differentials within individual cells, across multiple cells, and even between production lines. This technology allows for real-time insights into the electrical, thermal, and mechanical conditions of battery components, making it particularly valuable for industries such as automotive, residential storage, grid storage, and consumer electronics. Founded in 2015 and headquartered in Emeryville, California, Liminal is positioned to enhance battery performance and reliability through its advanced screening and analytics capabilities.

Lindy Biosciences

Series B in 2022
Lindy Biosciences, LLC is a development-stage company based in Durham, North Carolina, specializing in protein-based therapeutic formulations. Utilizing a technology known as microglassification, the company gently removes a significant portion of water from solutions of proteins and other biologics, resulting in solid, spherical, amorphous microbeads. These microbeads create stable, dense particles of therapeutic proteins suitable for various applications, including high-concentration injectable suspensions, encapsulation for controlled release, and long-term storage. Established in 2016, Lindy Biosciences aims to provide innovative solutions for the formulation of protein therapeutics, addressing the needs of medical researchers in developing advanced therapeutic options.

NALA Membranes

Seed Round in 2022
NALA Membranes specializes in the production of chlorine-stable reverse osmosis membranes designed to enhance water treatment efficiency while minimizing waste and energy consumption. Their patented materials create durable membranes that resist fouling and failure, making them suitable for demanding industrial wastewater applications. By offering solutions that lower operating costs and reduce greenhouse gas emissions, NALA Membranes supports both economic and environmental sustainability. The company's products are utilized across various sectors, including industrial, municipal, residential, and wastewater treatment systems, effectively addressing a range of contaminants and operating conditions.

The Pact

Seed Round in 2022
Pact is a company that specializes in muscle scanning technology aimed at enhancing athletic recovery. It offers a system that analyzes muscle conditions to develop personalized recovery solutions. The company's innovative massager is equipped with a full-feedback app that not only scans muscles but also determines their condition, allowing for tailored warm-up and recovery routines. This adaptive approach to massage treatment is designed to address specific injuries and improve long-term athletic performance. By focusing on individual needs, Pact aims to facilitate faster recovery for athletes.

Base Operations

Seed Round in 2021
Base Operations Inc. specializes in providing street-level threat analysis services through a comprehensive threat intelligence platform. Founded in 2015 and based in Washington, D.C., the company aggregates and visualizes both crowdsourced and official data to assist organizations in mitigating risks and ensuring the safety of their personnel and operations in emerging markets. Their offerings include detailed threat assessments, neighborhood threat ratings, and AI-powered predictive analytics, which enable clients to gain actionable insights for improved response times and security management. Additionally, the platform features a dashboard for security personnel, facilitating communication with field employees and enhancing trip management to safeguard against potential threats.

Pryon

Funding Round in 2021
Pryon Inc. is an artificial intelligence company based in Raleigh, North Carolina, that focuses on enhancing enterprise knowledge management. Founded in 2017 by Igor Jablokov, Pryon develops an augmented intelligence platform that combines human and machine capabilities to streamline access to information across various channels and sources. The platform employs natural language processing and automated machine learning to transform unstructured data into actionable insights, thereby boosting productivity and decision-making accuracy. By utilizing a no-code approach, Pryon enables organizations to quickly harness the value of their information assets without disrupting existing operations. The company's solutions aim to simplify AI adoption, reduce complexity, and lower costs for businesses seeking to improve their workflows and knowledge utilization.

Databento

Series A in 2021
Databento offers a streamlined platform for accessing financial market data, founded by professionals with backgrounds in trading and engineering from leading quantitative hedge funds. The company provides a self-service model that allows users to access live exchange feeds and vast amounts of historical data efficiently. Clients can choose between a pay-as-you-go system or flat-rate pricing, providing flexibility based on their needs. By hosting servers in colocation facilities at various trading venues, Databento ensures low-latency and high-fidelity data capture directly from the source. Its platform also automates data licensing and reduces onboarding time, making it easier for businesses and financial institutions to obtain reliable, institutional-grade data while minimizing storage costs.

Orbit Fab

Venture Round in 2021
Orbit Fab, Inc. is a company focused on developing orbital propellant depots to support satellite servicing and expand the operational capabilities of space assets. Founded in 2018 and headquartered in San Francisco, California, the company provides various products, including the Rapidly Attachable Fluid Transfer Interface (RAFTI) for on-orbit refueling and docking, as well as prototypes of rigid and flexible tankers for the International Space Station (ISS). By creating the necessary infrastructure for in-space fuel supply, Orbit Fab aims to foster a growing market for satellite maintenance and new industries such as space tourism, manufacturing, and mining. Their technology enhances the flexibility and operational lifespan of satellites, enabling operators to acquire fuel and materials as needed, thus transforming the way satellites are serviced in orbit.

Thiozen

Seed Round in 2021
Thiozen is a company based in Belmont, Massachusetts, that specializes in innovative hydrogen gas production technology aimed at reducing greenhouse gas emissions. Founded in 2020, Thiozen employs a unique chemical process that converts hydrogen sulfide into hydrogen gas. This method not only significantly lowers greenhouse gas emissions but also allows clients to bypass the carbon emissions typically associated with hydrogen production from natural gas and the high costs linked to electrolysis. By offering a low-cost and low-emission alternative, Thiozen positions itself as a key player in the transition to cleaner energy solutions.

Bone Health Technologies

Venture Round in 2021
Bone Health Technologies, Inc. is a health technology company based in Redwood City, California, focused on developing innovative solutions for individuals with low bone density. Incorporated in 2018, the company has created OsteoBoost, a wearable medical device that provides a non-invasive treatment to prevent osteoporosis. This FDA-cleared device is designed to be worn on the lower back and utilizes whole-body vibration technology to deliver mechanical stimulation to the hips and spine, mimicking the effects of weight-bearing exercise. Clinical studies have demonstrated OsteoBoost's efficacy in significantly slowing down the loss of bone density and strength, particularly in postmenopausal women with osteopenia. By offering a convenient, pain-free alternative to pharmacological treatments, Bone Health Technologies aims to improve health outcomes for the approximately 64 million Americans at risk of osteoporotic fractures.

Fisherman

Seed Round in 2021
Fisherman is a Boston-based company that offers a platform for independent restaurants to automatically create and manage their websites. Founded in 2018, the company utilizes available data to design custom websites tailored to the needs of these businesses. Its software is specifically developed for small and medium-sized enterprises, allowing users to generate modern, affordable websites equipped with robust search engine optimization and customer engagement capabilities. This enables restaurant owners to maintain a high-quality online presence without the need for hiring external agencies.

Blue Ocean Gear

Seed Round in 2021
Blue Ocean Gear specializes in the design and manufacture of advanced GPS tracking buoys, specifically engineered to meet the challenging demands of modern fixed gear fishing. Their innovative SmartBuoy product suite provides fishers, aquaculture farmers, and ocean scientists with the ability to track and monitor data from their equipment in real-time, regardless of location. This technology significantly improves operational efficiency and profitability by reducing fuel costs and minimizing the risk of lost gear, while also offering valuable insights into local ocean conditions. Additionally, Blue Ocean Gear's solutions contribute to addressing environmental issues related to marine plastic pollution and gear entanglement, promoting more sustainable management of ocean resources.

Databento

Convertible Note in 2021
Databento offers a streamlined platform for accessing financial market data, founded by professionals with backgrounds in trading and engineering from leading quantitative hedge funds. The company provides a self-service model that allows users to access live exchange feeds and vast amounts of historical data efficiently. Clients can choose between a pay-as-you-go system or flat-rate pricing, providing flexibility based on their needs. By hosting servers in colocation facilities at various trading venues, Databento ensures low-latency and high-fidelity data capture directly from the source. Its platform also automates data licensing and reduces onboarding time, making it easier for businesses and financial institutions to obtain reliable, institutional-grade data while minimizing storage costs.

Pienso

Venture Round in 2021
Pienso Inc. is a machine learning platform based in Brooklyn, New York, that specializes in transforming text data into actionable insights. Established in 2016, the company employs innovative lensing techniques to enhance both algorithms and user interactions, creating a real-time system for validation and adaptation. Its platform is designed specifically for non-programming analysts, researchers, and domain experts, allowing them to create and train machine learning models independently, without requiring external assistance. By providing feedback loops between users and machine analysis, Pienso facilitates improved data mining, prediction, and the visualization of associations, ultimately empowering its clientele to derive meaningful insights from their data.

Base Operations

Seed Round in 2021
Base Operations Inc. specializes in providing street-level threat analysis services through a comprehensive threat intelligence platform. Founded in 2015 and based in Washington, D.C., the company aggregates and visualizes both crowdsourced and official data to assist organizations in mitigating risks and ensuring the safety of their personnel and operations in emerging markets. Their offerings include detailed threat assessments, neighborhood threat ratings, and AI-powered predictive analytics, which enable clients to gain actionable insights for improved response times and security management. Additionally, the platform features a dashboard for security personnel, facilitating communication with field employees and enhancing trip management to safeguard against potential threats.

NALA Membranes

Funding Round in 2021
NALA Membranes specializes in the production of chlorine-stable reverse osmosis membranes designed to enhance water treatment efficiency while minimizing waste and energy consumption. Their patented materials create durable membranes that resist fouling and failure, making them suitable for demanding industrial wastewater applications. By offering solutions that lower operating costs and reduce greenhouse gas emissions, NALA Membranes supports both economic and environmental sustainability. The company's products are utilized across various sectors, including industrial, municipal, residential, and wastewater treatment systems, effectively addressing a range of contaminants and operating conditions.

Coagulo Medical Technologies

Venture Round in 2020
Coagulo Medical Technologies, Inc. is a Massachusetts-based company focused on developing advanced testing systems for coagulation management. The company provides a portable and connected precision-medicine platform that enables healthcare professionals to detect, identify, and quantify the effects of various anticoagulants in whole blood. By utilizing a combination of patent-pending coagulation assays, microfluidic technology, and data analytics, Coagulo's system offers actionable results, facilitating personalized diagnosis and management of coagulation-related conditions. This innovative approach aims to improve healthcare outcomes by making coagulation testing more accessible and efficient for both providers and patients.

Bone Health Technologies

Series A in 2020
Bone Health Technologies, Inc. is a health technology company based in Redwood City, California, focused on developing innovative solutions for individuals with low bone density. Incorporated in 2018, the company has created OsteoBoost, a wearable medical device that provides a non-invasive treatment to prevent osteoporosis. This FDA-cleared device is designed to be worn on the lower back and utilizes whole-body vibration technology to deliver mechanical stimulation to the hips and spine, mimicking the effects of weight-bearing exercise. Clinical studies have demonstrated OsteoBoost's efficacy in significantly slowing down the loss of bone density and strength, particularly in postmenopausal women with osteopenia. By offering a convenient, pain-free alternative to pharmacological treatments, Bone Health Technologies aims to improve health outcomes for the approximately 64 million Americans at risk of osteoporotic fractures.

Bone Health Technologies

Series A in 2020
Bone Health Technologies, Inc. is a health technology company based in Redwood City, California, focused on developing innovative solutions for individuals with low bone density. Incorporated in 2018, the company has created OsteoBoost, a wearable medical device that provides a non-invasive treatment to prevent osteoporosis. This FDA-cleared device is designed to be worn on the lower back and utilizes whole-body vibration technology to deliver mechanical stimulation to the hips and spine, mimicking the effects of weight-bearing exercise. Clinical studies have demonstrated OsteoBoost's efficacy in significantly slowing down the loss of bone density and strength, particularly in postmenopausal women with osteopenia. By offering a convenient, pain-free alternative to pharmacological treatments, Bone Health Technologies aims to improve health outcomes for the approximately 64 million Americans at risk of osteoporotic fractures.

Swift Solar

Venture Round in 2020
Swift Solar Inc. is a company that designs and manufactures lightweight solar panels and systems, focusing on advanced solar technology. Established in 2017 and headquartered in San Carlos, California, with an additional site in Golden, Colorado, Swift Solar specializes in perovskite solar cells, which are engineered to be more efficient and cost-effective than conventional solar panels. The company’s innovative approach involves creating ultra-thin perovskite films that absorb various parts of the solar spectrum, resulting in high-efficiency tandem solar cells. These cells not only enhance solar conversion efficiency but also provide significant weight advantages, making them suitable for applications in aerospace, automotive, and building sectors. Swift Solar emphasizes domestic manufacturing and utilizes abundant raw materials to ensure scalability in its operations.

X-COR Therapeutics

Seed Round in 2020
X-COR Therapeutics is a medical device company based in Allston, Massachusetts, founded in 2017. The company specializes in developing a novel CO2 removal device designed to treat patients experiencing acute respiratory failure. Its innovative system utilizes a hybrid approach, allowing for the extraction of excess CO2 from the blood through small catheters at ultra-low blood flows of less than 300 ml/min, which can be managed by nursing staff. This method offers a safer, more affordable, and more accessible treatment option compared to traditional extracorporeal devices that typically require higher blood flows and specialized physician intervention. X-COR's technology includes a patent-pending medical device and a machine-learning-based control algorithm, facilitating compatibility with existing medical infrastructure for ease of deployment. The company gained recognition as a runner-up in the 2018 Harvard President’s Innovation Challenge and participated in the MedTech Innovator and MassChallenge cohorts that same year.

Ateios

Seed Round in 2020
Ateios Inc. develops advanced technology for manufacturing ultra-thin and customizable batteries suitable for various applications in electronics. Based in Indianapolis, Indiana, the company was founded in 2018 and focuses on creating zinc-oxide batteries that offer 2-5 times higher energy density compared to traditional coin cells. This innovative manufacturing process enables the production of flexible batteries that can be tailored to fit specific product requirements. Ateios' technology is particularly applicable to smart textiles, soft robotics, Internet-of-Things (IoT) devices, and medical or fitness wearables. By facilitating a new generation of thin and flexible electronics, Ateios aims to enhance the integration of battery technology into diverse electronic devices.

Unison.Cloud

Seed Round in 2020
Unison.Cloud is a cloud platform developed by Unison Computing that leverages an open-source programming language designed to simplify software development. This platform enables users to run massively distributed Unison programs or small services on a global network of managed Unison nodes, allowing for efficient resource usage with a pay-as-you-go model. It offers seamless integration with non-Unison code and services while maintaining full compatibility with the broader Unison ecosystem. Key features of the Unison programming language include streamlined codebase management, dynamic code deployment without builds or dependency conflicts, and easy navigation through codebases, making it an accessible solution for developers looking to describe and manage elastic distributed systems.

Fluree

Seed Round in 2020
Fluree is a developer of a data management platform that focuses on secure data sharing and data-driven insights. Its platform utilizes a blockchain-secured semantic graph database to organize data, providing a scalable solution that establishes a foundational layer of trusted information for connected and intelligent ecosystems. By reducing the need for custom code and excessive APIs, Fluree enables data-first development across the entire technology stack, ensuring a single source of data truth. This approach allows clients to make their data tamper-proof while benefiting from a cloud-native architecture.

Encora Therapeutics

Pre Seed Round in 2020
Encora Therapeutics is a Boston-based company founded in 2018 that focuses on developing wearable technology and neurostimulation devices specifically for patients with neurological movement disorders. The company aims to provide personalized, non-invasive solutions that help individuals regain independence and control over their lives. By utilizing advanced signal processing and reinforcement learning techniques, Encora's devices are designed to alleviate tremors in the hands, offering affordable remedies that improve the quality of life for those affected by neurodegenerative conditions.

Ateios

Seed Round in 2020
Ateios Inc. develops advanced technology for manufacturing ultra-thin and customizable batteries suitable for various applications in electronics. Based in Indianapolis, Indiana, the company was founded in 2018 and focuses on creating zinc-oxide batteries that offer 2-5 times higher energy density compared to traditional coin cells. This innovative manufacturing process enables the production of flexible batteries that can be tailored to fit specific product requirements. Ateios' technology is particularly applicable to smart textiles, soft robotics, Internet-of-Things (IoT) devices, and medical or fitness wearables. By facilitating a new generation of thin and flexible electronics, Ateios aims to enhance the integration of battery technology into diverse electronic devices.

Eden

Convertible Note in 2020
Eden is focused on developing a sustainable platform for natural resource recovery, aiming to create a carbon-neutral future. The company has introduced a novel method known as Pulsed Electrical Well Stimulation (PEWS), which is a patent-pending technology designed to replace traditional hydraulic fracturing. This innovative approach eliminates the need for water injection and addresses the logistical challenges and environmental risks associated with conventional fracking methods. By utilizing high-voltage electricity and proprietary modeling techniques, Eden enhances rock permeability with precision, facilitating effective resource extraction across various geological settings. This technology not only reduces costs but also minimizes the negative impacts typically associated with hydraulic fracturing, positioning Eden as a leader in environmentally responsible resource recovery.

Radical Plastics

Seed Round in 2020
Radical Plastics, Inc., based in Winchester, Massachusetts, develops biodegradable plastic compounds designed to address plastic pollution. Incorporated in 2018, the company utilizes a proprietary, naturally occurring catalyst to blend with conventional plastics, making them fully biodegradable in the natural environment. Their innovative technology offers soil degradable compounds specifically for agricultural film, providing an economically viable solution for brands seeking drop-in replacements for traditional plastics. Through its commitment to sustainability, Radical Plastics aims to contribute to reducing plastic waste and promoting environmental health.

TrillBit

Convertible Note in 2020
Trillbit is a Boston-based startup founded in 2017, focused on developing a unique technology that utilizes inaudible sound waves for communication and authentication purposes. Backed by Techstars and Cisco Launchpad, the company has created a proprietary acoustic system that allows any speaker and microphone to function as a data transfer device. This near-ultrasonic communication technology enables secure, encrypted transmission of authentication information and data packets directly from speakers or media devices to smartphones, eliminating the need for traditional network connections and deployment costs. Trillbit's innovative approach leverages the widespread presence of audio speakers and smart devices, positioning the company to disrupt existing communication methods and enhance security in various applications. The startup has received recognition for its groundbreaking technology and potential impact in the field.

Obsidio

Venture Round in 2020
Obsidio, Inc. is a medical device company founded in 2018 and based in Solana Beach, California. The company specializes in developing shear-thinning hydrogel biomaterial technology, which is used to manufacture therapeutic devices and universal gel embolization materials. This technology allows for minimally invasive procedures to inject embolic materials through catheters, effectively stopping undesirable blood flow in vessels throughout the body. Obsidio's products are applicable in various medical scenarios, including the treatment of hemorrhages, aneurysms, and tumors, as well as managing conditions related to coagulopathy. By focusing on interventional radiology and oncology, Obsidio aims to provide precise and durable solutions for vascular occlusion.

Obsidio

Convertible Note in 2020
Obsidio, Inc. is a medical device company founded in 2018 and based in Solana Beach, California. The company specializes in developing shear-thinning hydrogel biomaterial technology, which is used to manufacture therapeutic devices and universal gel embolization materials. This technology allows for minimally invasive procedures to inject embolic materials through catheters, effectively stopping undesirable blood flow in vessels throughout the body. Obsidio's products are applicable in various medical scenarios, including the treatment of hemorrhages, aneurysms, and tumors, as well as managing conditions related to coagulopathy. By focusing on interventional radiology and oncology, Obsidio aims to provide precise and durable solutions for vascular occlusion.

Piction Health

Seed Round in 2020
Piction Health is a dermatology care service that provides patients with rapid access to expert dermatological consultations for skin, hair, or nail concerns. Through its application, the company facilitates a streamlined process where patients receive a diagnosis and personalized care plan within two days. Piction Health employs artificial intelligence to enhance the experience for both patients and healthcare providers, enabling primary care physicians to obtain quick second opinions on complex skin conditions. This approach not only improves patient outcomes but also reduces unnecessary repeat visits and ineffective treatments, ultimately accelerating access to high-quality dermatology care from the comfort of home.

Irys

Seed Round in 2020
Irys provides an AI-driven community engagement platform designed to enhance collaboration between businesses, organizations, and their stakeholders. The platform centralizes essential information, enabling clients to manage projects, communicate effectively, and gather feedback all in one space. By facilitating remote data collection from communities, Irys allows clients to gain actionable insights that inform their decisions and foster transparency. This approach not only streamlines the development of products and services but also supports the creation of sustainable neighborhoods, ultimately helping clients build trust and improve their decision-making processes.

Encora Therapeutics

Convertible Note in 2020
Encora Therapeutics is a Boston-based company founded in 2018 that focuses on developing wearable technology and neurostimulation devices specifically for patients with neurological movement disorders. The company aims to provide personalized, non-invasive solutions that help individuals regain independence and control over their lives. By utilizing advanced signal processing and reinforcement learning techniques, Encora's devices are designed to alleviate tremors in the hands, offering affordable remedies that improve the quality of life for those affected by neurodegenerative conditions.

Obsidio

Convertible Note in 2020
Obsidio, Inc. is a medical device company founded in 2018 and based in Solana Beach, California. The company specializes in developing shear-thinning hydrogel biomaterial technology, which is used to manufacture therapeutic devices and universal gel embolization materials. This technology allows for minimally invasive procedures to inject embolic materials through catheters, effectively stopping undesirable blood flow in vessels throughout the body. Obsidio's products are applicable in various medical scenarios, including the treatment of hemorrhages, aneurysms, and tumors, as well as managing conditions related to coagulopathy. By focusing on interventional radiology and oncology, Obsidio aims to provide precise and durable solutions for vascular occlusion.

Lindy Biosciences

Convertible Note in 2020
Lindy Biosciences, LLC is a development-stage company based in Durham, North Carolina, specializing in protein-based therapeutic formulations. Utilizing a technology known as microglassification, the company gently removes a significant portion of water from solutions of proteins and other biologics, resulting in solid, spherical, amorphous microbeads. These microbeads create stable, dense particles of therapeutic proteins suitable for various applications, including high-concentration injectable suspensions, encapsulation for controlled release, and long-term storage. Established in 2016, Lindy Biosciences aims to provide innovative solutions for the formulation of protein therapeutics, addressing the needs of medical researchers in developing advanced therapeutic options.

X-COR Therapeutics

Seed Round in 2020
X-COR Therapeutics is a medical device company based in Allston, Massachusetts, founded in 2017. The company specializes in developing a novel CO2 removal device designed to treat patients experiencing acute respiratory failure. Its innovative system utilizes a hybrid approach, allowing for the extraction of excess CO2 from the blood through small catheters at ultra-low blood flows of less than 300 ml/min, which can be managed by nursing staff. This method offers a safer, more affordable, and more accessible treatment option compared to traditional extracorporeal devices that typically require higher blood flows and specialized physician intervention. X-COR's technology includes a patent-pending medical device and a machine-learning-based control algorithm, facilitating compatibility with existing medical infrastructure for ease of deployment. The company gained recognition as a runner-up in the 2018 Harvard President’s Innovation Challenge and participated in the MedTech Innovator and MassChallenge cohorts that same year.

Aluna

Convertible Note in 2020
Aluna is focused on empowering patients with chronic respiratory conditions, particularly asthma, by providing tools for better understanding and management of their lung health. The company has developed a portable spirometer device that utilizes machine learning and integrates with a mobile app. This technology allows patients to take daily measurements of their asthma, track symptoms, medication use, exercise, and environmental factors. By objectively monitoring asthma severity, the device enables healthcare providers to detect early signs of asthma attacks and create personalized, real-time action plans for their patients. Aluna is committed to enhancing the quality of life for individuals with asthma through innovative medical devices and healthcare solutions.

Eden

Convertible Note in 2020
Eden is focused on developing a sustainable platform for natural resource recovery, aiming to create a carbon-neutral future. The company has introduced a novel method known as Pulsed Electrical Well Stimulation (PEWS), which is a patent-pending technology designed to replace traditional hydraulic fracturing. This innovative approach eliminates the need for water injection and addresses the logistical challenges and environmental risks associated with conventional fracking methods. By utilizing high-voltage electricity and proprietary modeling techniques, Eden enhances rock permeability with precision, facilitating effective resource extraction across various geological settings. This technology not only reduces costs but also minimizes the negative impacts typically associated with hydraulic fracturing, positioning Eden as a leader in environmentally responsible resource recovery.

Aluna

Convertible Note in 2020
Aluna is focused on empowering patients with chronic respiratory conditions, particularly asthma, by providing tools for better understanding and management of their lung health. The company has developed a portable spirometer device that utilizes machine learning and integrates with a mobile app. This technology allows patients to take daily measurements of their asthma, track symptoms, medication use, exercise, and environmental factors. By objectively monitoring asthma severity, the device enables healthcare providers to detect early signs of asthma attacks and create personalized, real-time action plans for their patients. Aluna is committed to enhancing the quality of life for individuals with asthma through innovative medical devices and healthcare solutions.

Unison.Cloud

Convertible Note in 2019
Unison.Cloud is a cloud platform developed by Unison Computing that leverages an open-source programming language designed to simplify software development. This platform enables users to run massively distributed Unison programs or small services on a global network of managed Unison nodes, allowing for efficient resource usage with a pay-as-you-go model. It offers seamless integration with non-Unison code and services while maintaining full compatibility with the broader Unison ecosystem. Key features of the Unison programming language include streamlined codebase management, dynamic code deployment without builds or dependency conflicts, and easy navigation through codebases, making it an accessible solution for developers looking to describe and manage elastic distributed systems.

Pienso

Seed Round in 2019
Pienso Inc. is a machine learning platform based in Brooklyn, New York, that specializes in transforming text data into actionable insights. Established in 2016, the company employs innovative lensing techniques to enhance both algorithms and user interactions, creating a real-time system for validation and adaptation. Its platform is designed specifically for non-programming analysts, researchers, and domain experts, allowing them to create and train machine learning models independently, without requiring external assistance. By providing feedback loops between users and machine analysis, Pienso facilitates improved data mining, prediction, and the visualization of associations, ultimately empowering its clientele to derive meaningful insights from their data.

Databento

Seed Round in 2019
Databento offers a streamlined platform for accessing financial market data, founded by professionals with backgrounds in trading and engineering from leading quantitative hedge funds. The company provides a self-service model that allows users to access live exchange feeds and vast amounts of historical data efficiently. Clients can choose between a pay-as-you-go system or flat-rate pricing, providing flexibility based on their needs. By hosting servers in colocation facilities at various trading venues, Databento ensures low-latency and high-fidelity data capture directly from the source. Its platform also automates data licensing and reduces onboarding time, making it easier for businesses and financial institutions to obtain reliable, institutional-grade data while minimizing storage costs.

ReviveMed

Convertible Note in 2019
ReviveMed Inc is a precision-medicine company based in Cambridge, Massachusetts, founded in 2016. It specializes in a platform that utilizes data from small molecules or metabolites to derive actionable insights. The company's technology employs a network-based machine learning algorithm for the integrative analysis of untargeted metabolomic data alongside large-scale molecular information, which includes data from genes, proteins, drugs, and diseases. This innovative approach enables researchers to develop in-house therapeutics specifically targeting patients with liver diseases and related conditions, thereby aiming to improve health outcomes through the unlocking of metabolomic data's potential.

Orbit Fab

Seed Round in 2019
Orbit Fab, Inc. is a company focused on developing orbital propellant depots to support satellite servicing and expand the operational capabilities of space assets. Founded in 2018 and headquartered in San Francisco, California, the company provides various products, including the Rapidly Attachable Fluid Transfer Interface (RAFTI) for on-orbit refueling and docking, as well as prototypes of rigid and flexible tankers for the International Space Station (ISS). By creating the necessary infrastructure for in-space fuel supply, Orbit Fab aims to foster a growing market for satellite maintenance and new industries such as space tourism, manufacturing, and mining. Their technology enhances the flexibility and operational lifespan of satellites, enabling operators to acquire fuel and materials as needed, thus transforming the way satellites are serviced in orbit.

Base Operations

Seed Round in 2019
Base Operations Inc. specializes in providing street-level threat analysis services through a comprehensive threat intelligence platform. Founded in 2015 and based in Washington, D.C., the company aggregates and visualizes both crowdsourced and official data to assist organizations in mitigating risks and ensuring the safety of their personnel and operations in emerging markets. Their offerings include detailed threat assessments, neighborhood threat ratings, and AI-powered predictive analytics, which enable clients to gain actionable insights for improved response times and security management. Additionally, the platform features a dashboard for security personnel, facilitating communication with field employees and enhancing trip management to safeguard against potential threats.

Fisherman

Convertible Note in 2019
Fisherman is a Boston-based company that offers a platform for independent restaurants to automatically create and manage their websites. Founded in 2018, the company utilizes available data to design custom websites tailored to the needs of these businesses. Its software is specifically developed for small and medium-sized enterprises, allowing users to generate modern, affordable websites equipped with robust search engine optimization and customer engagement capabilities. This enables restaurant owners to maintain a high-quality online presence without the need for hiring external agencies.

Obsidio

Seed Round in 2019
Obsidio, Inc. is a medical device company founded in 2018 and based in Solana Beach, California. The company specializes in developing shear-thinning hydrogel biomaterial technology, which is used to manufacture therapeutic devices and universal gel embolization materials. This technology allows for minimally invasive procedures to inject embolic materials through catheters, effectively stopping undesirable blood flow in vessels throughout the body. Obsidio's products are applicable in various medical scenarios, including the treatment of hemorrhages, aneurysms, and tumors, as well as managing conditions related to coagulopathy. By focusing on interventional radiology and oncology, Obsidio aims to provide precise and durable solutions for vascular occlusion.

Bone Health Technologies

Seed Round in 2019
Bone Health Technologies, Inc. is a health technology company based in Redwood City, California, focused on developing innovative solutions for individuals with low bone density. Incorporated in 2018, the company has created OsteoBoost, a wearable medical device that provides a non-invasive treatment to prevent osteoporosis. This FDA-cleared device is designed to be worn on the lower back and utilizes whole-body vibration technology to deliver mechanical stimulation to the hips and spine, mimicking the effects of weight-bearing exercise. Clinical studies have demonstrated OsteoBoost's efficacy in significantly slowing down the loss of bone density and strength, particularly in postmenopausal women with osteopenia. By offering a convenient, pain-free alternative to pharmacological treatments, Bone Health Technologies aims to improve health outcomes for the approximately 64 million Americans at risk of osteoporotic fractures.

Radical Plastics

Convertible Note in 2019
Radical Plastics, Inc., based in Winchester, Massachusetts, develops biodegradable plastic compounds designed to address plastic pollution. Incorporated in 2018, the company utilizes a proprietary, naturally occurring catalyst to blend with conventional plastics, making them fully biodegradable in the natural environment. Their innovative technology offers soil degradable compounds specifically for agricultural film, providing an economically viable solution for brands seeking drop-in replacements for traditional plastics. Through its commitment to sustainability, Radical Plastics aims to contribute to reducing plastic waste and promoting environmental health.

Obsidio

Convertible Note in 2019
Obsidio, Inc. is a medical device company founded in 2018 and based in Solana Beach, California. The company specializes in developing shear-thinning hydrogel biomaterial technology, which is used to manufacture therapeutic devices and universal gel embolization materials. This technology allows for minimally invasive procedures to inject embolic materials through catheters, effectively stopping undesirable blood flow in vessels throughout the body. Obsidio's products are applicable in various medical scenarios, including the treatment of hemorrhages, aneurysms, and tumors, as well as managing conditions related to coagulopathy. By focusing on interventional radiology and oncology, Obsidio aims to provide precise and durable solutions for vascular occlusion.

Leuko

Seed Round in 2019
Leuko Labs focuses on developing a non-invasive device for monitoring white blood cell counts, which is crucial for various medical situations, including chemotherapy management and the detection of severe infections. Their device, PointCheck, allows for frequent testing without the need for blood draws or laboratory infrastructure, making it more accessible for patients. This innovation aims to enhance the quality of life for immunosuppressed individuals and improve clinical outcomes by enabling healthcare providers to offer personalized treatment plans based on real-time data. By simplifying the process of white blood cell assessment, Leuko Labs contributes to more effective patient management and better survival rates.

Pryon

Series A in 2019
Pryon Inc. is an artificial intelligence company based in Raleigh, North Carolina, that focuses on enhancing enterprise knowledge management. Founded in 2017 by Igor Jablokov, Pryon develops an augmented intelligence platform that combines human and machine capabilities to streamline access to information across various channels and sources. The platform employs natural language processing and automated machine learning to transform unstructured data into actionable insights, thereby boosting productivity and decision-making accuracy. By utilizing a no-code approach, Pryon enables organizations to quickly harness the value of their information assets without disrupting existing operations. The company's solutions aim to simplify AI adoption, reduce complexity, and lower costs for businesses seeking to improve their workflows and knowledge utilization.

Obsidio

Convertible Note in 2019
Obsidio, Inc. is a medical device company founded in 2018 and based in Solana Beach, California. The company specializes in developing shear-thinning hydrogel biomaterial technology, which is used to manufacture therapeutic devices and universal gel embolization materials. This technology allows for minimally invasive procedures to inject embolic materials through catheters, effectively stopping undesirable blood flow in vessels throughout the body. Obsidio's products are applicable in various medical scenarios, including the treatment of hemorrhages, aneurysms, and tumors, as well as managing conditions related to coagulopathy. By focusing on interventional radiology and oncology, Obsidio aims to provide precise and durable solutions for vascular occlusion.

Eden

Convertible Note in 2019
Eden is focused on developing a sustainable platform for natural resource recovery, aiming to create a carbon-neutral future. The company has introduced a novel method known as Pulsed Electrical Well Stimulation (PEWS), which is a patent-pending technology designed to replace traditional hydraulic fracturing. This innovative approach eliminates the need for water injection and addresses the logistical challenges and environmental risks associated with conventional fracking methods. By utilizing high-voltage electricity and proprietary modeling techniques, Eden enhances rock permeability with precision, facilitating effective resource extraction across various geological settings. This technology not only reduces costs but also minimizes the negative impacts typically associated with hydraulic fracturing, positioning Eden as a leader in environmentally responsible resource recovery.

Swift Solar

Seed Round in 2019
Swift Solar Inc. is a company that designs and manufactures lightweight solar panels and systems, focusing on advanced solar technology. Established in 2017 and headquartered in San Carlos, California, with an additional site in Golden, Colorado, Swift Solar specializes in perovskite solar cells, which are engineered to be more efficient and cost-effective than conventional solar panels. The company’s innovative approach involves creating ultra-thin perovskite films that absorb various parts of the solar spectrum, resulting in high-efficiency tandem solar cells. These cells not only enhance solar conversion efficiency but also provide significant weight advantages, making them suitable for applications in aerospace, automotive, and building sectors. Swift Solar emphasizes domestic manufacturing and utilizes abundant raw materials to ensure scalability in its operations.

Base Operations

Convertible Note in 2019
Base Operations Inc. specializes in providing street-level threat analysis services through a comprehensive threat intelligence platform. Founded in 2015 and based in Washington, D.C., the company aggregates and visualizes both crowdsourced and official data to assist organizations in mitigating risks and ensuring the safety of their personnel and operations in emerging markets. Their offerings include detailed threat assessments, neighborhood threat ratings, and AI-powered predictive analytics, which enable clients to gain actionable insights for improved response times and security management. Additionally, the platform features a dashboard for security personnel, facilitating communication with field employees and enhancing trip management to safeguard against potential threats.

Rheos Gear

Seed Round in 2019
Rheos Gear designs, manufactures, and distributes polarized floating sunglasses specifically for boaters, fishers, and water enthusiasts. Founded in 2015, the company originated in Atlanta, Georgia, and is currently based in Charleston, South Carolina. Rheos Gear's products are available through various retail partners, catering to individuals who enjoy outdoor water activities.

The New Primal

Series D in 2019
The New Primal, LLC is a producer of healthy meat snacks, specializing in grass-fed beef and free-range turkey jerky. Founded in 2010 and headquartered in North Charleston, South Carolina, the company offers a diverse product line that includes meat sticks, beef thins, marinades, buffalo sauces, dressings, coconut aminos, seasonings, and BBQ sauces. In addition to its core snack offerings, The New Primal sells merchandise such as T-shirts and distributes its products through various channels, including online platforms, gyms, and grocery stores. The company focuses on making healthy eating habits accessible to consumers through its commitment to quality ingredients and innovative snack options.

Leuko

Seed Round in 2019
Leuko Labs focuses on developing a non-invasive device for monitoring white blood cell counts, which is crucial for various medical situations, including chemotherapy management and the detection of severe infections. Their device, PointCheck, allows for frequent testing without the need for blood draws or laboratory infrastructure, making it more accessible for patients. This innovation aims to enhance the quality of life for immunosuppressed individuals and improve clinical outcomes by enabling healthcare providers to offer personalized treatment plans based on real-time data. By simplifying the process of white blood cell assessment, Leuko Labs contributes to more effective patient management and better survival rates.

Lindy Biosciences

Series A in 2019
Lindy Biosciences, LLC is a development-stage company based in Durham, North Carolina, specializing in protein-based therapeutic formulations. Utilizing a technology known as microglassification, the company gently removes a significant portion of water from solutions of proteins and other biologics, resulting in solid, spherical, amorphous microbeads. These microbeads create stable, dense particles of therapeutic proteins suitable for various applications, including high-concentration injectable suspensions, encapsulation for controlled release, and long-term storage. Established in 2016, Lindy Biosciences aims to provide innovative solutions for the formulation of protein therapeutics, addressing the needs of medical researchers in developing advanced therapeutic options.

Skyhawk Therapeutics

Series A in 2019
Skyhawk Therapeutics is focused on the discovery and development of small molecule therapeutics aimed at correcting RNA expression. The company utilizes proprietary technology to design small molecules that specifically target binding pocket regions on RNA, ensuring both sequence and structural specificity during critical phases of RNA splicing. This innovative approach enables the development of therapies for various conditions, including cancer, neurological disorders, and rare diseases, particularly those associated with RNA mis-splicing known as exon skipping. Founded in 2015 and headquartered in Waltham, Massachusetts, Skyhawk Therapeutics was previously known as Rare Genetix before rebranding in 2018.

Aluna

Convertible Note in 2018
Aluna is focused on empowering patients with chronic respiratory conditions, particularly asthma, by providing tools for better understanding and management of their lung health. The company has developed a portable spirometer device that utilizes machine learning and integrates with a mobile app. This technology allows patients to take daily measurements of their asthma, track symptoms, medication use, exercise, and environmental factors. By objectively monitoring asthma severity, the device enables healthcare providers to detect early signs of asthma attacks and create personalized, real-time action plans for their patients. Aluna is committed to enhancing the quality of life for individuals with asthma through innovative medical devices and healthcare solutions.

Aluna

Seed Round in 2018
Aluna is focused on empowering patients with chronic respiratory conditions, particularly asthma, by providing tools for better understanding and management of their lung health. The company has developed a portable spirometer device that utilizes machine learning and integrates with a mobile app. This technology allows patients to take daily measurements of their asthma, track symptoms, medication use, exercise, and environmental factors. By objectively monitoring asthma severity, the device enables healthcare providers to detect early signs of asthma attacks and create personalized, real-time action plans for their patients. Aluna is committed to enhancing the quality of life for individuals with asthma through innovative medical devices and healthcare solutions.

Pryon

Seed Round in 2018
Pryon Inc. is an artificial intelligence company based in Raleigh, North Carolina, that focuses on enhancing enterprise knowledge management. Founded in 2017 by Igor Jablokov, Pryon develops an augmented intelligence platform that combines human and machine capabilities to streamline access to information across various channels and sources. The platform employs natural language processing and automated machine learning to transform unstructured data into actionable insights, thereby boosting productivity and decision-making accuracy. By utilizing a no-code approach, Pryon enables organizations to quickly harness the value of their information assets without disrupting existing operations. The company's solutions aim to simplify AI adoption, reduce complexity, and lower costs for businesses seeking to improve their workflows and knowledge utilization.

Unison.Cloud

Seed Round in 2018
Unison.Cloud is a cloud platform developed by Unison Computing that leverages an open-source programming language designed to simplify software development. This platform enables users to run massively distributed Unison programs or small services on a global network of managed Unison nodes, allowing for efficient resource usage with a pay-as-you-go model. It offers seamless integration with non-Unison code and services while maintaining full compatibility with the broader Unison ecosystem. Key features of the Unison programming language include streamlined codebase management, dynamic code deployment without builds or dependency conflicts, and easy navigation through codebases, making it an accessible solution for developers looking to describe and manage elastic distributed systems.

PT on Demand

Convertible Note in 2018
PT on Demand is an office management and marketing platform tailored for healthcare professionals, particularly in the therapy sector. It offers a comprehensive suite of features, including online scheduling, patient intake forms, payment processing, and electronic medical records (EMR) management. The platform also supports the creation and management of client exercise programs and includes telehealth capabilities, allowing for remote patient engagement. By streamlining administrative tasks, PT on Demand enables healthcare providers to focus more on patient care while enhancing operational efficiency and revenue potential. Its user-friendly interface is accessible via smartphones and computers, making it convenient for both practitioners and patients.

QuadWrangle

Convertible Note in 2018
QuadWrangle, Inc. is a Boston-based company that specializes in alumni engagement through its mobile application. Founded in 2011, the application leverages databases and social media to provide content and insights about alumni, including their interests and activities. It offers personalized feeds for users and facilitates networking opportunities at events, enhancing connections among alumni. Additionally, QuadWrangle's platform includes features that streamline event management, allowing users to plan events efficiently, process payments, and handle post-event follow-up. In November 2019, QuadWrangle became a subsidiary of Ruffalo Noel Levitz, LLC, further advancing its mission to foster happiness among alumni and translate that into institutional support.

Skyhawk Therapeutics

Venture Round in 2018
Skyhawk Therapeutics is focused on the discovery and development of small molecule therapeutics aimed at correcting RNA expression. The company utilizes proprietary technology to design small molecules that specifically target binding pocket regions on RNA, ensuring both sequence and structural specificity during critical phases of RNA splicing. This innovative approach enables the development of therapies for various conditions, including cancer, neurological disorders, and rare diseases, particularly those associated with RNA mis-splicing known as exon skipping. Founded in 2015 and headquartered in Waltham, Massachusetts, Skyhawk Therapeutics was previously known as Rare Genetix before rebranding in 2018.

Base Operations

Convertible Note in 2018
Base Operations Inc. specializes in providing street-level threat analysis services through a comprehensive threat intelligence platform. Founded in 2015 and based in Washington, D.C., the company aggregates and visualizes both crowdsourced and official data to assist organizations in mitigating risks and ensuring the safety of their personnel and operations in emerging markets. Their offerings include detailed threat assessments, neighborhood threat ratings, and AI-powered predictive analytics, which enable clients to gain actionable insights for improved response times and security management. Additionally, the platform features a dashboard for security personnel, facilitating communication with field employees and enhancing trip management to safeguard against potential threats.

Dynepic

Seed Round in 2018
Dynepic, Inc. is a company that specializes in developing connected toys and an open architecture cloud platform aimed at enhancing child-friendly content. Founded in 2011 and based in Charleston, South Carolina, Dynepic offers a range of innovative products, including The Internet of Toys, which is an open API platform that integrates various toys and technology to enrich children's play experiences. The company also features DynePod, a Bluetooth-connected, educational toy that engages children in programming and socialization through interactive programming. Additionally, Dynepic provides playPORTAL Studio, a suite of software development kits designed to ensure kid-safe authentication and compliance with child privacy laws in apps and connected toys. Dynepic's products are accessible for purchase through crowdfunding platforms, showcasing the company's commitment to merging play with technology in a secure environment.

Skyhawk Therapeutics

Series A in 2018
Skyhawk Therapeutics is focused on the discovery and development of small molecule therapeutics aimed at correcting RNA expression. The company utilizes proprietary technology to design small molecules that specifically target binding pocket regions on RNA, ensuring both sequence and structural specificity during critical phases of RNA splicing. This innovative approach enables the development of therapies for various conditions, including cancer, neurological disorders, and rare diseases, particularly those associated with RNA mis-splicing known as exon skipping. Founded in 2015 and headquartered in Waltham, Massachusetts, Skyhawk Therapeutics was previously known as Rare Genetix before rebranding in 2018.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.